Profitelligence Profitelligence · Filing Ledger Open ABT research →

Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-03-23

Orville Jacob A Files Abbott Laboratories (ABT) Form 4 - March 23, 2026

Orville Jacob A bought 13.3K ABT shares in this Form 4 filing, reported to the SEC on 2026-03-23.

Insider
Orville Jacob A
Issuer
Abbott Laboratories ABT · NYSE
Filed
Period
2026-03-23
Accession
0001263312-26-000004

Transactions (1)

Insider Date Type Shares Price Value Own
Orville Jacob A 2026-03-23 Buy 13.3K $0.00 $0.00 Direct
Net change+13.3K$0.00

About Abbott Laboratories

Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.

Exchange NYSE Industry Medical Devices Company website ↗

Track ABT insider activity

Get alerted when Abbott Laboratories executives buy or sell their shares.

Set up free alerts